BJL
NUVB icon

Brighton Jones LLC’s Nuvation Bio NUVB Stock Holding History

Brighton Jones LLC’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424K Buy
74,632
+600
+0.8% +$2.93K 0.01% 870
2026
Q1 		$318K Buy
+74,032
New +$412K 0.01% 907
2025
Q4 		– Sell
-73,163
Closed -$271K – 653
2025
Q3 		$271K Buy
73,163
+11,502
+19% +$31.3K 0.01% 848
2025
Q2 		$120K Buy
+61,661
New +$128K ﹤0.01% 887

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Brighton Jones LLC's NUVB Position: Q2 2026 in Review

Brighton Jones LLC increased its Nuvation Bio (NUVB) stake by 0.81% in Q2 2026, buying an estimated $2.93K and bringing the position to 74,632 shares worth $424K. The position accounts for 0.01% of the portfolio, ranked #870.

Brighton Jones LLC first reported a position in NUVB in Q2 2025 and has held it in 4 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Brighton Jones LLC held 74,632 shares of Nuvation Bio worth $424K as of Q2 2026.
  • Brighton Jones LLC bought 600 Nuvation Bio shares in Q2 2026, an estimated $2.93K.
  • Nuvation Bio made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #870 holding.
  • Brighton Jones LLC first reported a position in Nuvation Bio in Q2 2025 and has held it in 4 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.